| Ticker Details |
Mannatech, Incorporated Common Stock
Mannatech Inc develops and sells nutritional supplements, topical and skin care products, and weight-management products. Its products portfolio includes Ambrotose complex, Ambrotose AO, NutriVerus, and OsoLean, among others.
|
| IPO Date: |
February 16, 1999 |
| Sector: |
Consumer Staples |
| Industry: |
Personal Products |
| Market Cap: |
$12.2M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.35 | 2.90%
|
| Avg Daily Range (30 D): |
$0.17 | 3.36%
|
| Avg Daily Range (90 D): |
$0.23 | 4.49%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.06M |
| Avg Daily Volume (30 D): |
.01M |
| Avg Daily Volume (90 D): |
.02M |
| Trade Size |
| Avg Trade Size (Sh.): |
211 |
| Avg Trade Size (Sh.) (30 D): |
68 |
| Avg Trade Size (Sh.) (90 D): |
72 |
| Institutional Trades |
| Total Institutional Trades: |
107 |
| Avg Institutional Trade: |
$1.02M |
| Avg Institutional Trade (30 D): |
$M |
| Avg Institutional Trade (90 D): |
$M |
| Avg Institutional Trade Volume: |
.01M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.3M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
38.92K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-3.91
|
$.53
|
$.49
|
|
Diluted EPS
|
$-3.91
|
$.53
|
$.49
|
|
Revenue
|
$107.36M
|
$26.65M
|
$24.92M
|
|
Gross Profit
|
$81.67M
|
$20.49M
|
$18.86M
|
|
Net Income / Loss
|
$-7.41M
|
$1.02M
|
$.95M
|
|
Operating Income / Loss
|
$2.67M
|
$1M
|
$-.18M
|
|
Cost of Revenue
|
$25.69M
|
$6.16M
|
$6.06M
|
|
Net Cash Flow
|
$1.38M
|
$-.57M
|
$.87M
|
|
PE Ratio
|
|
|
|
|
|
|
